Selecting certain patients for D-dimer testing appears to be a safe and more efficient way of diagnosing deep vein thrombosis (DVT) than uniformly testing all patients suspected of having the ...

Overreliance on D-dimer testing and similarity to other conditions may mean pulmonary embolism or venous thromboembolism is ...

The Global D-Dimer Testing Market is valued at approximately USD 1.37 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 5.1% over the forecast period 2024-2032. The ...

February 10, 2023 – Measurement of plasma D-dimer levels – a test more commonly used to detect blood-clotting disorders – can provide useful information when making the difficult diagnosis of ...

Ottawa, ON - Performing a D-dimer test in addition to clinical assessment of patients with suspected deep vein thrombosis (DVT) simplifies diagnosis of the disorder, a new randomized study has shown.

The growing prevalence of thrombotic disorders and the rising focus on personalized medicine & precision healthcare are projected to drive the global D-dimer testing market's growth during the ...

Austin, Aug. 05, 2025 (GLOBE NEWSWIRE) -- D-dimer Testing Market Size & Growth Analysis: According to SNS Insider, The D-dimer Testing Market was valued at USD 1.83 billion in 2023 and is projected to ...

D-dimer is often an underutilized test in the evaluation and management of emergency roon patients. This presentation focuses on the clinical use of D-dimer testing in the Emergency Department, ...

Tampa, FL (Oct. 26, 2021) --A screening blood test originally validated in seriously ill patients without COVID-19 is still clinically useful for ruling out pulmonary embolism in patients hospitalized ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Back to Healio Compared with fixed D-dimer testing, a ...

A targeted computerized alert at the time of physician order entry reduced the use of D-dimer testing among patients 65 years and older. A single-crossover cluster randomized trial of computerized ...